Bull case
NTR would need investors to value it at roughly 41x earnings — about 28x more generous than today's 13x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where NTR stock could go
NTR would need investors to value it at roughly 41x earnings — about 28x more generous than today's 13x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing NTR — at roughly 13x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 11x multiple contraction could push NTR down roughly 83% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Nutrien is a global agricultural inputs company that produces and distributes crop nutrients and related services. It generates revenue primarily from potash and nitrogen fertilizer sales (roughly 60% combined) and its retail distribution network of crop protection products, seeds, and services. The company's key advantage is its integrated business model—combining low-cost production of key nutrients with the world's largest agricultural retail network—which creates significant scale and logistical efficiencies.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $0.11/$0.33 | -66.7% | $5.1B/$5.1B | -0.9% |
| Q3 2025 | $2.65/$2.40 | +10.4% | $10.4B/$10.4B | -0.1% |
| Q4 2025 | $0.97/$0.93 | +4.3% | $5.9B/$5.2B | +13.2% |
| Q1 2026 | $0.83/$0.87 | -4.6% | $5.1B/$5.4B | -5.6% |
NTR beat EPS estimates in 2 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $86 — implies +14.6% from today's price.
| Metric | NTR | S&P 500 | Basic Materials | 5Y Avg NTR |
|---|---|---|---|---|
| Forward PE | 13.0x | 19.1x-32% | 15.4x-16% | — |
| Trailing PE | 15.6x | 25.2x-38% | 22.9x-32% | 17.5x-11% |
| PEG Ratio | 0.38x | 1.75x-78% | 1.22x-69% | — |
| EV/EBITDA | 7.5x | 15.3x-51% | 11.4x-34% | 6.3x+19% |
| Price/FCF | 17.4x | 21.3x-18% | 27.5x-37% | 14.1x+24% |
| Price/Sales | 1.3x | 3.1x-59% | 2.0x-34% | 1.1x+18% |
| Dividend Yield | 3.01% | 1.88% | 1.37% | 3.42% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolNTR returns 4.6% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~6.2 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Nutrien’s earnings are heavily tied to fertilizer prices. Volatility driven by global supply‑demand, input costs, and geopolitical events can erode margins. A prolonged price decline would materially reduce revenue.
Analysts estimate intrinsic value below the current market price, indicating limited upside. Industry cyclicality adds uncertainty, raising the risk of overvaluation.
With a Debt to Free Cash Flow ratio of 6.00, Nutrien would take several years to repay debt, raising solvency concerns. This could limit flexibility for growth or dividend policy.
Disruptions in global supply chains, such as those around the Strait of Hormuz, can tighten fertilizer supply and squeeze margins. Vulnerabilities expose Nutrien to operational risk and potential cost increases.
Nutrien’s production relies on natural gas and other inputs; fluctuations in these costs can materially affect earnings. Rising input prices could erode profitability.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Nutrien is the world’s largest fertilizer producer by capacity, holding a 20% share of installed capacity. The company reports record potash sales volumes and solid free cash flow, underpinning its market leadership.
Strong potash demand is projected to drive sales and price growth through 2026, positioning Nutrien to capture a larger share of the expanding fertilizer market.
A recent filing for a US$5 billion shelf registration grants Nutrien significant financial flexibility for future capital raising, supporting growth initiatives and shareholder returns.
Nutrien has increased its quarterly dividend, signaling a clear commitment to returning value to shareholders and reinforcing investor confidence.
Fertilizer prices have risen due to supply constraints in the Middle East, boosting Nutrien’s revenue and margin prospects.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
NTR NTR Nutrien Ltd. | $35.5B | 13.0x | +1.4% | 8.4% | Buy | +14.1% |
MOS MOS The Mosaic Company | $7.5B | 16.1x | +3.3% | 10.5% | Hold | +32.6% |
CF CF CF Industries Holdings, Inc. | $18.4B | 8.5x | +0.2% | 23.7% | Buy | -9.1% |
ICL ICL ICL Group Ltd | $7.3B | 14.6x | +1.5% | 5.2% | Hold | +9.4% |
SMG SMG The Scotts Miracle-Gro Company | $3.6B | 14.3x | -3.5% | 2.7% | Buy | +14.6% |
AVD AVD American Vanguard Corporation | $83M | 7.7x | -1.3% | -8.7% | Buy | +484.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
NTR returns 4.6% total yield, led by a 3.01% dividend, raised 8 consecutive years. Buybacks add another 1.6%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.55 | — | — | — |
| 2025 | $2.18 | +0.9% | 1.9% | 5.5% |
| 2024 | $2.16 | +1.9% | 0.8% | 5.6% |
| 2023 | $2.12 | +10.4% | 3.7% | 7.4% |
| 2022 | $1.92 | +4.3% | 11.5% | 14.1% |
Common questions answered from live analyst data and company financials.
Nutrien Ltd. (NTR) is rated Buy by Wall Street analysts as of 2026. Of 33 analysts covering the stock, 20 rate it Buy or Strong Buy, 10 rate it Hold, and 3 rate it Sell or Strong Sell. The consensus 12-month price target is $84, implying +14.1% from the current price of $74. The bear case scenario is $13 and the bull case is $233.
The Wall Street consensus price target for NTR is $84 based on 33 analyst estimates. The high-end target is $100 (+35.5% from today), and the low-end target is $75 (+1.6%). The base case model target is $74.
NTR trades at 13.0x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals slightly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for NTR in 2026 are: (1) Fertilizer Price Volatility — Nutrien’s earnings are heavily tied to fertilizer prices. (2) Valuation Uncertainty — Analysts estimate intrinsic value below the current market price, indicating limited upside. (3) Debt to FCF Ratio — With a Debt to Free Cash Flow ratio of 6. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates NTR will report consensus revenue of $27.3B (+1.4% year-over-year) and EPS of $4.97 (+5.8% year-over-year) for the upcoming fiscal year. The following year, analysts project $27.2B in revenue.
Nutrien Ltd. is expected to report its next earnings on approximately 2026-05-06. Consensus expects EPS of $0.47 and revenue of $5.3B. Over recent quarters, NTR has beaten EPS estimates 33% of the time.
Nutrien Ltd. (NTR) generated $2.0B in free cash flow over the trailing twelve months — a free cash flow margin of 7.4%. NTR returns capital to shareholders through dividends (3.0% yield) and share repurchases ($561M TTM).